title: Fc receptor-like 3 -169 C/T polymorphism and RA susceptibility: a meta-analysis.
abstract: The Fc receptor-like 3 (FCRL3) -169 C/T polymorphism has been reported to be associated with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), but with inconsistent results. The aim of this study was to explore whether the FCRL3 -169 C/T polymorphism confers susceptibility to RA and SLE. The authors conducted a random effect meta-analysis on the associations between the C/C (recessive effect) or C/C + C/T (dominant effect) genotype or the allele C of the FCRL3 -169 polymorphisms and RA or SLE in different populations. In total, 15 separate comparisons, 12 for RA and 3 for SLE, drawn from nine European and six Asian population samples were included in this meta-analysis. No association between RA and the FCRL3 C allele was found for all study subjects (OR = 1.064, 95% CI = 0.987-1.146, p = 0.107). However, stratification by ethnicity indicated that the FCRL3 C allele was significantly associated with RA in Asians (OR = 1.203, 95% CI = 1.097-31.319, p < 0.001). Conversely, no association was detected for this allele and RA in Europeans (OR = 0.997, 95% CI = 0.931-1.068, p = 0.933). The ORs for the C/C + C/T and C/C genotypes in these ethnic groups showed the same trends as the FCRL3 C allele. An association between SLE and the FCRL3 -169 A allele was found in all study subjects (OR = 1.115, 95% CI = 1.003-1.240, p = 0.043), but meta-analysis excluding studies with controls not in HWE did not show the association. This meta-analysis suggests that the FCRL3 -169 C/T polymorphism is a significant risk factor for RA in Asians, but not in Europeans.
authors.affiliation: Division of Rheumatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 126-1 5-ga, Anam-dong, Seongbuk-gu, Seoul, 136-705, Korea. lyhcgh@korea.ac.kr
authors.forename: Young Ho
authors.initials: YH
authors.lastname: Lee
authors.forename: Jin-Hyun
authors.initials: JH
authors.lastname: Woo
authors.forename: Seong Jae
authors.initials: SJ
authors.lastname: Choi
authors.forename: Jong Dae
authors.initials: JD
authors.lastname: Ji
authors.forename: Gwan Gyu
authors.initials: GG
authors.lastname: Song
mesh_terms: D001172:Arthritis, Rheumatoid / Q000208:ethnology / Q000235:genetics*; D044466:Asian People / Q000235:genetics; D001483:Base Sequence / Q000235:genetics; D005787:Gene Frequency / Q000235:genetics; D005819:Genetic Markers / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D040582:Inheritance Patterns / Q000235:genetics; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011971:Receptors, Immunologic / Q000235:genetics*; D044465:White People / Q000235:genetics
chemical_list: C457775:FCRL3 protein, human; D005819:Genetic Markers; D011971:Receptors, Immunologic
references.citation: Stat Med. 2002 Jun 15;21(11):1539-58
references.pmid: 12111919
references.citation: Ann Rheum Dis. 1991 Jun;50(6):343-6
references.pmid: 2059076
references.citation: Nat Genet. 2005 May;37(5):478-85
references.pmid: 15838509
references.citation: Rheumatology (Oxford). 2006 Feb;45(2):166-70
references.pmid: 16278286
references.citation: Ann Rheum Dis. 2006 May;65(5):671-3
references.pmid: 16176992
references.citation: Springer Semin Immunopathol. 2006 Oct;28(2):119-30
references.pmid: 17021721
references.citation: BMJ. 1997 Sep 13;315(7109):629-34
references.pmid: 9310563
references.citation: Rheumatology (Oxford). 2006 Aug;45(8):1044-6
references.pmid: 16717063
references.citation: Hum Mol Genet. 2005 Aug 15;14(16):2305-21
references.pmid: 16000323
references.citation: Immunol Rev. 2002 Dec;190:123-36
references.pmid: 12493010
references.citation: Arthritis Res Ther. 2006;8(4):R117
references.pmid: 16859508
references.citation: Arthritis Rheum. 2006 Mar;54(3):1022-5
references.pmid: 16508985
references.citation: Rheumatol Int. 2007 Jul;27(9):827-33
references.pmid: 17265154
references.citation: BMJ. 1997 Dec 6;315(7121):1533-7
references.pmid: 9432252
references.citation: J Clin Endocrinol Metab. 2007 Mar;92(3):1106-11
references.pmid: 17200162
references.citation: Rheumatology (Oxford). 2007 Jan;46(1):49-56
references.pmid: 16760194
references.citation: Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335-71
references.pmid: 2858114
references.citation: Arthritis Rheum. 2002 May;46(5):1242-54
references.pmid: 12115230
references.citation: Arthritis Rheum. 2006 Dec;54(12):3838-41
references.pmid: 17133581
references.citation: Arthritis Rheum. 2007 Sep;56(9):3168-71
references.pmid: 17763442
references.citation: Arthritis Rheum. 2006 Dec;54(12):3820-7
references.pmid: 17133579
references.citation: N Engl J Med. 1990 May 3;322(18):1277-89
references.pmid: 2271017
references.citation: Ann Rheum Dis. 2006 Sep;65(9):1188-91
references.pmid: 16476711
references.citation: Ann Rheum Dis. 2007 Jun;66(6):803-6
references.pmid: 17179172